本页面由Tiger Trade Technology Pte. Ltd.提供服务

Organon & Co

6.36
+0.22003.58%
盘后6.360.00000.00%18:37 EDT
成交量:339.68万
成交额:2,132.04万
市值:16.53亿
市盈率:8.83
高:6.37
开:6.04
低:5.95
收:6.14
52周最高:14.70
52周最低:5.69
股本:2.60亿
流通股本:2.59亿
量比:1.05
换手率:1.31%
股息:0.08
股息率:1.26%
每股收益(TTM):0.7200
每股收益(LYR):0.7200
净资产收益率:30.56%
总资产收益率:6.22%
市净率:2.20
市盈率(LYR):8.83

数据加载中...

公司资料

公司名字:
Organon & Co
交易所:
NYSE
成立时间:
1923
员工人数:
10000
公司地址:
30 Hudson Street,Floor 33,Jersey City,New Jersey,United States
邮编:
07302
电话:
传真:
- -
简介:
Organon & Co.是一家于2020年3月11日在特拉华州注册成立的公司。该公司是一家全球性的医疗保健公司,其使命是提供有影响力的药物和解决方案,让每一天都更健康。该公司在女性健康和普通药物领域拥有70多种产品组合,其中包括生物仿制药,专注于满足对女性有独特、不成比例或不同影响的健康需求,同时在140多个国家和地区扩大基本治疗的可及性。

董事

名称
职位
Alan Ezekowitz
Independent Director
Carrie S. Cox
Interim Executive Chair, Independent Director
Cynthia M. Patton
Independent Director
Deborah Leone
Independent Director
Grace Puma
Independent Director
Helene Gayle
Independent Director
Philip Ozuah
Independent Director
Robert Essner
Lead Independent Director
Rochelle B. Lazarus
Independent Director
Shalini Sharp
Independent Director

股东

名称
职位
Joseph Morrissey
Executive Vice President and Head of Manufacturing and Supply, Interim Chief Executive Officer
Matthew Walsh
Executive Vice President and Chief Financial Officer
Aaron Falcione
Executive Vice President and Chief Human Resources Officer
Daniel Karp
Executive Vice President, Corporate Development
Juan Camilo Arjona Ferreira
Executive Vice President, Head of Research & Development and Chief Medical Officer
Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
Rachel Stahler
Executive Vice President and Chief Digital & Growth Officer
Vittorio Nisita
Executive Vice President and Head of Enterprise Services & Solutions